Lataa...
Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema
BACKGROUND: Hereditary angioedema is characterized by recurrent attacks of angioedema of the skin, larynx, and gastrointestinal tract. Bradykinin is the key mediator of symptoms. Icatibant is a selective bradykinin B2 receptor antagonist. METHODS: In two double-blind, randomized, multicenter trials,...
Tallennettuna:
| Julkaisussa: | N Engl J Med |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4662377/ https://ncbi.nlm.nih.gov/pubmed/20818888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa0906393 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|